Association of new functional SNP rs72689236 of CASP3 with kawasaki disease: A meta-Analysis

Chinese Journal of Contemporary Pediatrics

Volumn 15, Issue 6, 2013, Pages 477-483

  Peng, Qian ^a   Chen, Chang Hui ^a   Wu, Qing ^a   Yang, Yuan ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

CASP3; Coronary artery lesion; Intravenous immunoglobulin; Kawasaki disease; Meta analysis

Indexed keywords

IMMUNOGLOBULIN;

ALLELE; ARTICLE; CASPASE 3 GENE; CORONARY ARTERY DISEASE; GENE; HUMAN; META ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

CASPASE 3; CORONARY ARTERY DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880901173     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: 10.7499/j.issn.1008-8830.2013.06.019     Document Type: Article

References (24)

1. Newburger JW, Takahashi M., Gerber MA., Gewitz MH, Tani LY., Bums JC. el al. Diagnosis, treatment, and long-term management of Kawasaki disease; a statement for health professionals from the Committee on Rheumatic Fever, Fndocaiditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Pediatrics. 2004, 114 ( 6); 1708-1733.
2. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingeis and toes in children [J]. Arenigi, 1967. 16 (3); 178-222.
3. Kato II, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Iaing-term consequences of Kawasaki disease. A 10-to 21 -year follow-up study of 594 patients [J]. Circulation, 1996. 94 ( 6); 1379-1385.
4. Onouchi Y. Molecular genetics of Kawasaki disease [J]. Pediatr Res. 2009. 65 (5 Pt 2 ) : 46R-54R.
5. Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease [J]. Hum Mol Genet, 2010. 19 ( 14 ) : 2898- 2906.
6. Onouchi Y., Gunji T., Bums JC, Shimizu C, Newburger JW, Yashi-ro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary arteiy aneu- rysms[J]. Nature Genet, 2008, 40 ( 1) : 3542.
7. The Japan Kawasaki Disease Research Committee. Diagnostic Guidelines Of Kawasaki Disease (5th Revised Edition ) [ DB/OI.J. [2002- 02 ]. http;//www.kawasaki-disease, org/diagnostic/index, html.
8. Wallace CA., French JW., Kahn SJ., Sheny DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease J. Pediatrics. 2000, 105 ( 6) : e78.
9. Horwitz HI., Feinstein AR. Methodologic standards and contradictory results in case-control research [J]. AmJMed. 1979. 66 (4) : 556-564.
10. Centre for Evidence-based Medicine. Systematic Review (critical appraisal sheet) [ DB/OL]. L 2005 J. http://www.cebm.net.
11. Lohmueller KF., Pearce CL., Pike M., Lander ES, Hirschhorn JN. Meta-Analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease J. Nat Genet. 2003. 33 (2) : 177-182.
12. Gong YG., Wu CN., Xing QH, Zhao XZ., Zhu J., He L. A two- method meta-Analysis of Neuregulin I ( NRG1 ) association and heterogeneity in schizophrenia J. Schizophr Res. 2009. 111 ( 1- 3) : 109-114.
13. Kuo HC., Yu HR., Juo SH., Yang KD., Wang YS., Liang CD. et al. CASP3 gene single-nucleotide polymoiphism ( rs72689236) and Kawasaki disease in Taiwanese children J.JHum Genet, 2011. 56 (2) : 161-165.
14. Onouchi Y., Suzuki Y., Suzuki H., Terai M., Yasukawa K., Hamada H. et al. ITPKC and CASP3 polymorphisms and risks for IV1G unresponsiveness and coronary artery lesion formation in Kawasaki disease[J] - Pharmacogenomics J. 2013, 13( 1 ) : 52-59.
15. Hata A, Onouchi Y. Susceptibility penes for Kawasaki disease; toward implementation of personalized medicine J.JHum Genet, 2009, 54 (2) : 67-73.
16. Wang CL, Wu YT., Liu CA, Kuo HC., Yang KD. Kawasaki disease; infection, immunity and genetics [J]. Pediatr Infect Dis J. 2005, 24 (11) : 998-1004.
17. Cheung YF., Huang GY., Chen SB., Liu XQ., Xi L., Liang XC, et al. Inflammatoiy gene polymorphisms and susceptibility to kawasa- ki disease and its arterial sequelae J. Pediatrics. 2008. 122 (3) : e608-e614.
18. Lin YJ., Wan L., Wu JY., Sheu JJ., Lin CW., Lan YC., et al. HLA- E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronaly artery aneurysms J. Arthritis Rheum. 2009. 60 ( 2); 604-610.
19. Khor CC., Davila S., Breunis WB., YC., Shimizu C., Wright VJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease J. Nat Genet. 2011. 43 ( 12) : 1241-1246.
20. Onouchi Y, Ozaki K., Burns JC, Shimizu C, Terai M, Hama da H, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease [J]. Nat Genet, 2012. 44 ( 5) : 517-521.
21. Lee YC, Kuo HC., Chang JS, Chang LY, Huang LM, Chen MR. et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis J. Nat Genet. 2012. 44 (5) : 522-525.
22. Burgner D., Davila S, Breunis WB., Ng SB., Li Y, Bonnard C, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease J. PLoS Genet. 2009. 5(1): e1000319.
23. Kim JJ., Hong YM, Sohn S, Jang GY., Ha KS., Yun SW. et al. A genome-wide association analysis reveals Ip31 and 2pl3. 3 as susceptibility loci for Kawasaki disease [J]-. Hum Genet. 2011. 129 (5) : 487-495.
24. Tsai FJ., Lee YC, Chang JS, Huang LM, Huang FY., Chiu NC, et al. Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study [J]. PLoS One. 2011. 6(2) : e16853.